TheEdgeResearch
Home / Stocks / BDMD

Baird Medical Investment Holdings Limited (BDMD)

NASDAQ Healthcare Medical - Devices
$1.17 ▲ +0.17%
Market Cap
$49.5M
Sector
Healthcare
Industry
Medical - Devices
Beta
-1.15
52-Wk Range
0.757-3.75
CEO
Haimei Wu
Country
CN
Currency
USD

Baird Medical Investment Holdings Limited operates in the Medical - Devices industry of the Healthcare sector, headquartered in Guangzhou, GD, CN. The stock last traded at $1.17, up 0.17% on the session, giving a market capitalisation of $49.5M. On trailing twelve-month figures it carries a trailing P/E of -1.20, a net margin of -121.0%. Its beta of -1.15 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-1.20
Price / Sales
2.19
Price / Book
1.08
EV / EBITDA
-2.83
Gross margin
83.8%
Operating margin
-113.7%
Net margin
-121.0%
Return on equity
Debt / equity
0.62
Current ratio
1.70
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ Capital Market
Employees
146
IPO date
2021-12-16
Headquarters
Guangzhou, GD, CN
About Baird Medical Investment Holdings Limited

Based in China, Baird Medical Investment Holdings Limited and its associated entities specialize in engineering and commercializing microwave ablation medical apparatus. These sophisticated instruments are employed in the minimally invasive management of a diverse array of benign and malignant tumors, notably targeting thyroid nodules, hepatic carcinomas, pulmonary cancers, and mammary lesions. The organization was established in 2012, with its corporate headquarters situated in Guangzhou, China.

Comparable companies

Baird Medical Investment Holdings Limited is most often compared with the following Healthcare names:

BDSXBEATCTSOECORFGENICCMNMTCNOTVOKURRBOT
More research on BDMD
BDMD technical analysis BDMD TheEdge Score Compare against peers
Open full interactive analysis & DCF →